Capra Biosciences Raises $1.8M in Pre-Seed Funding Capra Biosciences, a Manassas, VA-based firm centered on sustainable manufacturing of petrochemical replacements utilizing their biofilm bioreactor platform, raised $1.8m in pre-seed funding. Pre-seed traders embody Prithvi Ventures; the E14 Fund; GS Futures; Antimo’s president — Wes Osbourn; Savantus Ventures; Asymmetry Ventures; the Decarbonization Consortium; and SOSV, amongst others. The corporate intends to make use of the funds to construct its production-scale reactor and prolong its capabilities to incorporate the manufacturing of lubricants. Co-founded by Elizabeth Onderko, CEO, and Andrew Magyar, chief know-how officer, Capra Biosciences works on the intersection of biology and {hardware} engineering to construct a brand new type of steady stream bioreactor that leverages the distinctive options of their platform organism. Its first product is retinol, a beauty ingredient utilized in anti-aging merchandise. Positioned within the Prince William Science Accelerator, the corporate emerged from the aggressive IndieBio program backed by SOSV.